Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.